Background: We report the interim results from XCiDaBLE: A large prospective. observational "naturalistic" study evaluating Xeomin® (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the United States. Methods: Subjects with CD are followed for 2 treatment cycles and monitored via Interactive Voice/Web Response. Subject-reported scales include the Subject Global Impre... https://www.coraldinernyc.com/product-category/push/